<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9	Drug Interactions: Changes in Pharmacokinetic Parameters for Coadministered Drugs in the Presence of Cobicistat<footnote>All interaction studies conducted in healthy subjects.</footnote>
</caption>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="14%"></col>
<col align="center" valign="middle" width="6%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<thead>
<tr>
<th rowspan="2" stylecode="Lrule Rrule">Coadministered Drug</th>
<th rowspan="2" stylecode="Rrule Botrule">Dose of Coadministered Drug (mg)</th>
<th rowspan="2" stylecode="Rrule Botrule">TYBOST Dose (mg)</th>
<th rowspan="2" stylecode="Rrule Botrule">N</th>
<th colspan="3" stylecode="Rrule Botrule">Mean Ratio of Coadministered Drug Pharmacokinetic Parameters (90% CI);<br/>No effect = 1.00</th>
</tr>
<tr>
<th stylecode="Rrule">C<sub>max</sub>
</th>
<th stylecode="Rrule">AUC</th>
<th stylecode="Rrule">C<sub>tau</sub>
</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Desipramine</td>
<td stylecode="Rrule">50 single dose</td>
<td stylecode="Rrule">150 once daily</td>
<td stylecode="Rrule">8</td>
<td stylecode="Rrule">1.24<br/>(1.08, 1.44)</td>
<td stylecode="Rrule">1.65<br/>(1.36, 2.02)</td>
<td stylecode="Rrule">NC<content stylecode="bold">
<footnote id="ft1">NC = Not Calculated.</footnote>
</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Digoxin</td>
<td stylecode="Rrule">0.5 single dose</td>
<td stylecode="Rrule">150 once daily</td>
<td stylecode="Rrule">22</td>
<td stylecode="Rrule">1.41<br/>(1.29, 1.55)</td>
<td stylecode="Rrule">1.08<br/>(1.00, 1.17)</td>
<td stylecode="Rrule">NC<footnoteref idref="ft1"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz</td>
<td stylecode="Rrule">600 single dose</td>
<td stylecode="Rrule">150 once daily</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">0.87<br/>(0.80, 0.94)</td>
<td stylecode="Rrule">0.93<br/>(0.89, 0.97)</td>
<td stylecode="Rrule">NC<footnoteref idref="ft1"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifabutin</td>
<td rowspan="2" stylecode="Rrule">150 once every other day</td>
<td rowspan="2" stylecode="Rrule">150 once daily<footnote id="ft2">Study was conducted in the presence of 150 mg elvitegravir.</footnote>
</td>
<td rowspan="2" stylecode="Rrule">12</td>
<td stylecode="Rrule">1.09<br/>(0.98, 1.20)<footnote id="ft3">Comparison based on rifabutin 300 mg once daily.</footnote>
</td>
<td stylecode="Rrule">0.92<br/>(0.83, 1.03)<footnoteref idref="ft3"></footnoteref>
</td>
<td stylecode="Rrule">0.94<br/>(0.85, 1.04)<footnoteref idref="ft3"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">25-O-desacetyl-rifabutin</td>
<td stylecode="Rrule">4.84<footnoteref idref="ft3"></footnoteref>
<br/>(4.09, 5.74)</td>
<td stylecode="Rrule">6.25<footnoteref idref="ft3"></footnoteref>
<br/>(5.08, 7.69)</td>
<td stylecode="Rrule">4.94<footnoteref idref="ft3"></footnoteref>
<br/>(4.04, 6.04)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Rosuvastatin</td>
<td stylecode="Rrule">10 single dose</td>
<td stylecode="Rrule">150 single dose<footnoteref idref="ft2"></footnoteref>
</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">1.89<br/>(1.48, 2.42)</td>
<td stylecode="Rrule">1.38<br/>(1.14, 1.67)</td>
<td stylecode="Rrule">1.43<footnote>Parameter is C<sub>last</sub>
</footnote>
<br/>(1.08, 1.89)</td>
</tr>
</tbody>
</table>